tradingkey.logo

Alpha Teknova Inc

TKNO
4.460USD
-0.190-4.09%
收盘 12/22, 16:00美东报价延迟15分钟
238.72M总市值
亏损市盈率 TTM

Alpha Teknova Inc

4.460
-0.190-4.09%

关于 Alpha Teknova Inc 公司

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.

Alpha Teknova Inc简介

公司代码TKNO
公司名称Alpha Teknova Inc
上市日期Jun 25, 2021
CEOGunstream (Stephen)
员工数量173
证券类型Ordinary Share
年结日Jun 25
公司地址2451 Bert Drive
城市HOLLISTER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编95023
电话18316371100
网址https://www.teknova.com/
公司代码TKNO
上市日期Jun 25, 2021
CEOGunstream (Stephen)

Alpha Teknova Inc公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Alex Herzick
Alex Herzick
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Lab Essentials
7.79M
75.75%
Clinical Solutions
2.06M
20.03%
Other
435.00K
4.23%
地区USD
名称
营收
占比
United States
9.78M
95.04%
International
510.00K
4.96%
业务
地区
业务USD
名称
营收
占比
Lab Essentials
7.79M
75.75%
Clinical Solutions
2.06M
20.03%
Other
435.00K
4.23%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Telegraph Hill Partners
70.46%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.80%
Balyasny Asset Management LP
1.84%
其他
18.21%
持股股东
持股股东
占比
Telegraph Hill Partners
70.46%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.80%
Balyasny Asset Management LP
1.84%
其他
18.21%
股东类型
持股股东
占比
Private Equity
70.46%
Individual Investor
10.71%
Investment Advisor
6.44%
Investment Advisor/Hedge Fund
4.68%
Hedge Fund
2.15%
Research Firm
0.65%
Bank and Trust
0.08%
Pension Fund
0.04%
其他
4.80%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
143
45.32M
84.68%
-1.67M
2025Q2
134
49.86M
93.29%
-910.00K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
2023Q2
176
26.14M
92.65%
-5.67M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Telegraph Hill Partners
37.72M
70.48%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.15%
--
--
Apr 22, 2025
UBS Financial Services, Inc.
1.58M
2.96%
+424.17K
+36.58%
Jun 30, 2025
Balyasny Asset Management LP
1.00M
1.87%
+163.53K
+19.54%
Jun 30, 2025
Roubaix Capital, LLC
439.94K
0.82%
+439.94K
--
Jun 30, 2025
Mackowski J Matthew
820.81K
1.53%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.53%
+701.77K
+589.51%
Apr 22, 2025
The Vanguard Group, Inc.
652.18K
1.22%
+78.74K
+13.73%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
615.90K
1.15%
+480.11K
+353.57%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ProShares Nanotechnology ETF
0.52%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
查看更多
ProShares Nanotechnology ETF
占比0.52%
Invesco Nasdaq Biotechnology ETF
占比0.03%
ProShares Ultra Nasdaq Biotechnology
占比0.03%
iShares Biotechnology ETF
占比0.01%
iShares Micro-Cap ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
iShares Russell 2000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares UltraPro Russell2000
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Alpha Teknova Inc的前五大股东是谁?

Alpha Teknova Inc 的前五大股东如下:
Telegraph Hill Partners持有股份:37.72M,占总股份比例:70.48%。
Davis (Ted)持有股份:1.89M,占总股份比例:3.53%。
Davis (Irene)持有股份:1.69M,占总股份比例:3.15%。
UBS Financial Services, Inc.持有股份:1.58M,占总股份比例:2.96%。
Balyasny Asset Management LP持有股份:1.00M,占总股份比例:1.87%。

Alpha Teknova Inc的前三大股东类型是什么?

Alpha Teknova Inc 的前三大股东类型分别是:
Telegraph Hill Partners
Davis (Ted)
Davis (Irene)

有多少机构持有Alpha Teknova Inc(TKNO)的股份?

截至2025Q3,共有143家机构持有Alpha Teknova Inc的股份,合计持有的股份价值约为45.32M,占公司总股份的84.68%。与2025Q2相比,机构持股有所增加,增幅为-8.61%。

哪个业务部门对Alpha Teknova Inc的收入贡献最大?

在FY2025Q2,Lab Essentials业务部门对Alpha Teknova Inc的收入贡献最大,创收7.79M,占总收入的75.75%。
KeyAI